-
2
-
-
0020731443
-
Treatment of rosacea with 1% Metronidazole Cream
-
Gamborg Nielsen, P. (1983). Treatment of rosacea with 1% Metronidazole Cream. Brit. J. Dermatol., 108, 327-332.
-
(1983)
Brit. J. Dermatol.
, vol.108
, pp. 327-332
-
-
Gamborg Nielsen, P.1
-
3
-
-
0023174781
-
Topical metronidazole therapy for rosacea
-
Bleicher, P. A., Charles, J. J. and Sober, A. J. (1987). Topical metronidazole therapy for Rosacea. Arch. Dermatol., 123, 59-61.
-
(1987)
Arch. Dermatol.
, vol.123
, pp. 59-61
-
-
Bleicher, P.A.1
Charles, J.J.2
Sober, A.J.3
-
5
-
-
0016465513
-
Susceptibility of anaerobic bacteria to metronidazole: Relative resistance of nonspore-forming Gram-positive bacilli
-
Chow, A. W., Patten, V. and Guze, L. (1975). Susceptibility of anaerobic bacteria to metronidazole: relative resistance of nonspore-forming Gram-positive bacilli. J. Infect. Dis., 131, 182-186.
-
(1975)
J. Infect. Dis.
, vol.131
, pp. 182-186
-
-
Chow, A.W.1
Patten, V.2
Guze, L.3
-
6
-
-
0030876161
-
Therapy for acne vulgaris
-
Leydon, J. L. Therapy for acne vulgaris (1997). New Eng. J. Med., 336, 1156-1162.
-
(1997)
New Eng. J. Med.
, vol.336
, pp. 1156-1162
-
-
Leydon, J.L.1
-
7
-
-
0020082276
-
Sensitivity of Gardnerella vaginalis to metabolites of metronidazole and tinidazole
-
Shanker, S. and Munro, R. (1982). Sensitivity of Gardnerella vaginalis to metabolites of metronidazole and tinidazole. Lancet, 1, 167.
-
(1982)
Lancet
, vol.1
, pp. 167
-
-
Shanker, S.1
Munro, R.2
-
8
-
-
0023611328
-
Susceptibility of Campylobacter species to metronidazole, its bioactive metabolites and tinidazole
-
Bannatyne, R. M., Jackowski, J. and Karmali, M. A. (1987). Susceptibility of Campylobacter species to metronidazole, its bioactive metabolites and tinidazole. Infect., 15, 457-458.
-
(1987)
Infect.
, vol.15
, pp. 457-458
-
-
Bannatyne, R.M.1
Jackowski, J.2
Karmali, M.A.3
-
9
-
-
0024488740
-
New findings on the antibacterial interactions between cefotaxime and desacetylcefotaxime
-
Symposium (1989). New findings on the antibacterial interactions between cefotaxime and desacetylcefotaxime. Diag. Microbiol. Infect. Dis., 12, 23-121.
-
(1989)
Diag. Microbiol. Infect. Dis.
, vol.12
, pp. 23-121
-
-
-
10
-
-
0025851390
-
Activity of clarithromycin and its principal human metabolite against Haemophilus influenzae
-
Jorgensen, J. H., Maher, L. A. and Howell, A. W. (1991). Activity of clarithromycin and its principal human metabolite against Haemophilus influenzae. Antimic. Agents Chemother., 35, 1524-1526.
-
(1991)
Antimic. Agents Chemother.
, vol.35
, pp. 1524-1526
-
-
Jorgensen, J.H.1
Maher, L.A.2
Howell, A.W.3
-
11
-
-
0026666065
-
Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives
-
Lau, A. H., Lam, N. P., Piscitelli, S. C., Wilkes, L. and Danziger, L. H. (1992). Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives. Clin. Pharmacokin., 23, 523-531.
-
(1992)
Clin. Pharmacokin.
, vol.23
, pp. 523-531
-
-
Lau, A.H.1
Lam, N.P.2
Piscitelli, S.C.3
Wilkes, L.4
Danziger, L.H.5
|